The psychopharmacology of European herbs with cognition-enhancing properties.

  title={The psychopharmacology of European herbs with cognition-enhancing properties.},
  author={David O. Kennedy and Andrew Scholey},
  journal={Current pharmaceutical design},
  volume={12 35},
Extensive research suggests that a number of plant-derived chemicals and traditional Oriental herbal remedies possess cognition-enhancing properties. Widely used current treatments for dementia include extracts of Ginkgo biloba and several alkaloidal, and therefore toxic, plant-derived cholinergic agents. Several non-toxic, European herbal species have pan-cultural traditions as treatments for cognitive deficits, including those associated with ageing. To date they have not received research… 

Tables from this paper

Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
A multi‐faceted review of medicinal plants or phytochemicals, including traditional uses, relevant bioactivities, psychological and clinical evidence on efficacy and safety, focuses on those for which there is promising clinical trial evidence in people with dementia, together with at least one other of these lines of supporting evidence.
Neurocognitive effects of herbal extracts
Abstract: The chapter summarises the evidence pertaining to the biobehavioural effects of selected herbal extracts, concentrating on evidence from well-controlled human trials. The focus is on
Potential benefits of phytochemicals against Alzheimer's disease
  • E. Wightman
  • Biology
    Proceedings of the Nutrition Society
  • 2017
The present paper will look at the more benign terpene and phenolic phytochemicals; arguing that they offer a safer alternative and that, as well as demonstrating efficacy in cholinesterase inhibition, these phytochemicalicals are able to target other salient systems such as cerebral blood flow, free radical scavenging, anti-inflammation, glucoregulation and interaction with other neurotransmitters.
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers
The overall pattern of results is consistent with a dose-related benefit to processes involved in efficient stimulus processing and/or memory consolidation rather than retrieval or working memory efficiency.
improves cognitive performance and mood in healthy adults ) with cholinesterase inhibiting properties
Oral consumption of an in vitro investigation of the cholinesterase inhibitory properties and phytochemical constituents of a S. lavandulaefolia essential oil led to improved performance of secondary memory and attention tasks, and reduced mental fatigue and increased alertness which were more pronounced 4-h post-dose.
Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
The results extend previous observations of improved cognitive performance and mood following AChE inhibitory sage extracts and suggest that the ability of well-tolerated terpenoid-containing extracts to beneficially modulate cholinergic function and cognitive performance deserves further attention.
Herbal Cognitive Enhancers: New Developments and Challenges for Therapeutic Applications
Encouraging findings are now emerging in treating cognitive aging and dementia with natural products, and the future holds a great promise for this field.
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
This mini-review aimed to recapitulate last decade studies on the anti-AChE activity of plant species, their respective extracts, as well as isolated compounds to help researchers out with the bioprospection of potentially new AChEi drugs.
1 Lamiaceae Family Plants as a Potential Anticholinesterase Source in the Treatment of Alzheimer ’ s Disease Alzheimer
Studies on the discovery of new cholinesterase inhibitors from natural sources, particularly from Lamiaceae family plants were evaluated, and a number of terpenoids and phenolics/flavonoids isolated are presented as potential drugs in the treatment of Alzheimer’s disease.
Cognition Enhancing Effect of Rosemary Plant (Rosmarinus officinalis, L) in Preclinical Studies: A Systematic Review and Meta-Analysis
R.O improves cognitive function and its active constituents in enhancing the cognition and was anticholinesterase, procholinergic, antioxidant, anti-amyloid, neuroprotective and anti-inflammatory agent.


Of three plants with reputed memory enhancing properties, extracts of sage (Salvia officinalis) inhibited the brain enzyme in a concentration dependant manner, indicating that the active plant constituent(s) may be an as yet unidentified compound(s).
Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy **
The value of an integrative traditional and modern scientific approach to developing new treatments for dementia, but also in the understanding of disease mechanisms, is considered.
Medicinal Plant Extracts for the Treatment of Dementia
Current available data indicate galantamine to be well tolerated in the long term, with a relative lack of toxicity at clinically effective dosages, and future development of effective novel therapeutic strategies for dementia may benefit from the combination of conventional Western medical science and traditional Oriental medical practices.
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial
Modulation of Mood and Cognitive Performance Following Acute Administration of Single Doses of Melissa Officinalis (Lemon Balm) with Human CNS Nicotinic and Muscarinic Receptor-Binding Properties
D doses of Melissa officinalis at or above the maximum employed here can improve cognitive performance and mood and may therefore be a valuable adjunct in the treatment of Alzheimer's disease.
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial
The objective of this study was to assess the efficacy and safety of Salvia officinalis extract using a fixed dose (60 drops/day), in patients with mild to moderate Alzheimer's disease, over a 4‐month period.
Recent approaches to novel anti-Alzheimer therapy.
A novel drug--TV3326--was designed, based upon two pharmacophores: the carbamate moiety from rivastigmine, an AChE inhibitor; and the propargyl group from rasagiline, a MAO inhibitor, which may be expected to contribute positively to the cognitive benefits of Alzheimer's patients.
New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease.
New tacrine derivatives are being synthesized that keep their ability to inhibit AChE but that interfere with neuronal calcium overloading and prevent apoptosis, which could be useful in the treatment of neurodegenerative and ischaemic brain diseases.
[Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent].
The product seams to have a central slight antidopaminergic action without side effects and is an effective agent in the treatment of menopausal symptoms.